U.S. Markets closed

MAKO Surgical weakness a buying opportunity, says Piper Jaffray

Piper Jaffray views MAKO Surgical's preliminary Q4 results as a sign the company's story is back on track following the procedures dip in Q3. The firm said it would use any weakness today in the stock as a buying opportunity and reiterates an Overweight rating on the name.